NDC 71610-720 – Terazosin

Terazosin Hydrochloride 2 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC71610-720

Product details

Brand name
Terazosin
Generic name
Terazosin Hydrochloride
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA075317
Marketed since
December 20, 2004
Listing expires
December 31, 2026
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Terazosin →

Package NDC codes (7)

Package NDCDescriptionSince
71610-720-3030 CAPSULE in 1 BOTTLE (71610-720-30)Jul 18, 2023
71610-720-5360 CAPSULE in 1 BOTTLE (71610-720-53)Jul 18, 2023
71610-720-6090 CAPSULE in 1 BOTTLE (71610-720-60)Jul 18, 2023
71610-720-70120 CAPSULE in 1 BOTTLE (71610-720-70)Jul 18, 2023
71610-720-80180 CAPSULE in 1 BOTTLE (71610-720-80)Jul 18, 2023
71610-720-92270 CAPSULE in 1 BOTTLE (71610-720-92)Jul 18, 2023
71610-720-94360 CAPSULE in 1 BOTTLE (71610-720-94)Jul 18, 2023

Other Terazosin products